Heart failure patients with primary prevention implantable cardioverter defibrillator
Conditions
Interventions
None listed
Sponsors
Tokyo Women's Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Heart failure patients with primary prevention implantable cardioverter defibrillator
Exclusion criteria
Exclusion criteria: HCM, ARVC, Brugada/LQT/idiopathic VF
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relationship between pharmacological and non-pharmacological treatments and incidence of arrhythmia | — |
Countries
Japan
Contacts
Public ContactAtsushi Suzuki
Tokyo Women's Medical University Department of Cardiology
Outcome results
None listed